The Precision Health Initiative is conducted by Genuity Science. Learn more about our recent restructure here.

Precision Health Initiative
Data Controller

Genuity Science (Ireland) Limited is responsible for the management and control of all EU Research Data in the Precision Health Initiative.
We are deeply committed to the ethical and responsible stewardship and use of all Research Data in a safe and secure manner in compliance with all applicable laws, including GDPR and the Irish Health Research Regulations.

Board of Directors

Anne Jones, PhD,
Board Director

Chief Operating Officer,
Genuity Science
Managing Director,
Genuity Science (Ireland) Ltd.

“Genomics is the key to unlocking the potential of precision medicine.”

Anne Jones brings over 25 years’ experience working in the life science, chemical analysis and diagnostics arenas, in Ireland, the UK and the USA, working across a broad range of markets, products and functions.
Prior to joining Genuity Science, Anne was Vice President and General Manager for Pall Corporations Lab, Food & Beverage business at US-based Danaher Corp. She also held senior roles in strategy development and planning at Agilent Technologies where she led business development and M&A activities for Agilent’s $2.3B Life Sciences and Applied Markets division and developed the strategy for Agilent’s successful entry into cell analysis. She also worked with Amersham Biosciences in the UK and GE Healthcare Life Sciences in the UK and USA in marketing and R&D roles.
A graduate of National University of Ireland, Galway, in Microbiology and Molecular Biology, Anne completed her PhD at Cancer Research UK, studying protein biochemistry and molecular biology with focus on human DNA repair where she isolated a critical protein and elucidated its function in DNA repair, publishing this work in the highly-cited journals, ‘Nature’ and ‘J Biol. Chem’.

Paul Saunders, PhD,
Board Director

Senior Investment Director – Innovation, Ireland Strategic Investment Fund

Paul is Head of Innovation and Special Investments for the Ireland Strategic Investment Fund. Paul heads the fund’s investment agenda targeting large, transformative ‘Big Idea’ opportunities.
Prior to joining the Fund, Paul worked as Head of Innovation for the state-owned provider of postal services in the Republic of Ireland, An Post, working on initiatives in diverse areas including digital, payments, logistics, telecoms and retail. Paul has also worked as Group Development Director for Greencore, Bioenergy Development Director for NTR, and as Senior Consultant with McKinsey and Co., in Dublin and London. Paul started his career with Shell International in the Netherlands in various roles in geophysics, operations management, project economics and asset development.
Paul has a BSc in Physics from Bristol University, a PhD in Earthquake Physics from Cambridge University and an MBA from Insead.

Dyann Heward-Mills,
Board Director

Ethics Expert, European Commission and CEO, HewardMills

Before founding HewardMills, Dyann was a Partner at Baker McKenzie leading the Data Protection and Cyber Security practice group in London. She advised on a range of information law matters including employee investigations, data subject requests and data breach management.
Dyann’s career includes Senior Privacy Counsel for GE Capital, providing global support and advice on privacy and data protection matters, and at Linklaters where, as the senior privacy and communications lawyer, she had global responsibility for data protection compliance. Advising on all areas of data protection law and compliance, Dyann is particularly known in the data protection arena for taking clients through the complexities and onerous process of Binding Corporate Rules (BCRs).
She is a leading authority in the media, frequently giving technical advice at panel discussions, conferences and on the radio. She has published several articles and regularly appears as a guest lecturer. She has also been appointed as an ethics expert for the European Commission in research and innovation.